Gastrointestinal Cancer
From the Journals
The Last 30 Days: How Oncologists’ Choices Affect End-of-Life Cancer Care
Researchers analyze data from more than 17,000 patients who died of cancer between 2012 and 2017.
From the Journals
Ancient Viruses in Our DNA Hold Clues to Cancer Treatment
Targeting remnants of a virus in our DNA could lead to more effective cancer treatment with fewer side effects.
Feature
Breakthrough Blood Test for Colorectal Cancer Gets Green Light
The test’s approval could make it more likely that people get screened for and survive the disease.
Conference Coverage
Risk Stratification May Work Well for FIT-Based CRC Screening in Elderly
Fecal immunochemical tests could play a major role in risk stratification, researchers said.
Feature
Greater Transparency of Oncologists’ Pharma Relationships Needed
Reducing industry payments to hematologists and oncologists could benefit patients, say experts.
Feature
Is Immunotherapy Best for Unresectable HCC with Moderate Liver Dysfunction?
A new study compares outcomes following two paths of care for patients with unresectable hepatocellular carcinoma.
From the Journals
‘Chemoresistance Can Be Reversed’: Toughest Cancers Targeted
New research “shows the importance of the tumor microenvironment and its properties in dictating how cancer progresses and responds to drug...
From the Journals
Targeted Pancreatic Cancer Screening May Save Lives
High-risk individuals were significantly more likely to be diagnosed with early-stage pancreatic cancer compared with the general population, in a...
From the Journals
Does Extended Postop Follow-Up Improve Survival in Gastric Cancer?
Researchers investigate the potential benefit of extended cancer surveillance post gastrectomy using Korean National Health Insurance claims data...
From the Journals
Factors Linked to Complete Response, Survival in Pancreatic Cancer
Researchers investigate the incidence and factors associated with pathologic complete response after preoperative chemo(radio)therapy in patients...
Feature
How Aspirin May Lower Risk for Colorectal Cancer
These new data suggest that aspirin helps activate the immune system, which helps explain its potential chemopreventive effect in CRC.